Discover more from Grow’s Newsletter
🌱 The Grow Newsletter: Pre-registration closes tonight! 🚨
Exclusive access before we open to the public early next week ✨
A newsletter all about cannabis medicines, that offers patient and business perspectives written by the team at Grow.
🌱 This week, in the world of cannabis medicine:
→ Hear from Alex, Grow’s secret weapon for putting patients first
→ Grow updates: We’re in the news! And we’ve hit 90% of our goal pledges for our crowdfunding!
→ Patient perspectives: Steven Spencer
→ Tips to Grow
Hey - great to meet you! 👋
It has been a busy week at Grow, as we kicked off our first crowdfunding campaign, which is also the first crowdfunder by a British cannabis medicine start-up!
As Head of Patient Outreach, I’m thrilled to see so many people joining our community. As a patient myself, my role is super rewarding as I get to help people access treatments that truly work.
And now that it has closed, a big thank you to all of you who have pre-registered! We’re blown away by your support in taking Grow to the next level, and helping change more patient lives!
However, as a thank-you to signing up for this newsletter there’s still time left to join pre-registration - but not much! Until midnight tonight you can sign up here, as can your friends and family too, to get exclusive access to convert your pledge to actual investment before we open to the general public early next week. 💚
→🚨 We reached 90% of our crowdfunding target: We’ve had an incredible start to our crowdfunding campaign thanks to all of you wonderful folks - your support totally surpassed our expectations! We are on track to be oversubscribed! If you’re still keen to invest before the masses next week, pre-register here.
And if you join pre-registration, watch out for an email from us tomorrow morning with more news on how to invest 👀
→ ❤️ Close friends: Every week we highlight some of our close friends and partners who are doing great things for patients (If you’d like to be featured in the coming weeks, get in touch!). This week it’s Cannabis Access Clinics on Harley Street, who recently published this article looking at how cannabis medicines could help combat symptoms of ‘Long Covid’. Read their science backed case here.
“I turned to cannabis medicines after previous prescription drugs gave me terrible, and unliveable, side effects. At the time, there was only one clinic in the North that offered these prescriptions, which I only came across through my own research - it wasn’t offered to me as a solution otherwise.
Cannabis medicines have changed my life immeasurably. I no longer live a life of constant pain, fatigue, or physical and mental restriction - and, most importantly, it has given me the chance to to be the dad I want to be. I have regained my energy and creativity - meaning I can finally play with my children again and cope with whatever life throws at me.
Since learning more about this plant, I wholeheartedly believe that more people should be able to access these medicines, and that they should be offered as a first line of treatment. They’ve changed my life - and they can change yours, too.”
Tips to Grow 💪
🌱 Get daily news, community chat & crowdfunding updates on Twitter & LinkedIn.
🌱 Want to knowledge share with us? You can drop us a note here.
🌱 Share our plans with your pals and tell them about the massive positive potential of cannabis medicines.
Thanks for reading, see you next week 👋👋👋
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Seedrs does not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications from Seedrs, through email or any other medium, should be construed as an investment recommendation.
This email has been approved as a financial promotion by Seedrs Limited.